Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
Calcium supplement Calcium supplement
Calcium supplement and Sodium Reducing Agents, Potassium...
Upcoming
Antithrombotic enzymes Antithrombotic enzymes
Antithrombotic enzymes and its peer markets - Platelet aggregation inhibitors excl. heparin,
Upcoming
Hematological Enzymes Hematological Enzymes
Hematological Enzymes and its peer markets - Other hem products,
Upcoming
Peripheral vasodilator enzymes Peripheral vasodilator enzymes
Peripheral vasodilator enzymes and its peer markets - E-Clinical Trial Solutions,
Upcoming
Agents for treatment of hemorrhoids and anal fissures for topical use Agents for treatment of hemorrhoids and anal fissures for topical use
Agents for treatment of hemorrhoids and anal fissures for topical use and its peer markets - Immunoassay,
Upcoming
Cytotoxic antibiotics and related substances Cytotoxic antibiotics and related substances
Cytotoxic antibiotics and related substances and its peer markets - Proteomics,
Upcoming
TEG/Thrombelastrography TEG/Thrombelastrography
TEG/Thrombelastrography and ROTEM/Rotational Thromboelastrometry and
Upcoming
ROTEM/Rotational Thromboelastrometry ROTEM/Rotational Thromboelastrometry
ROTEM/Rotational Thromboelastrometry and TEG/Thrombelastrography and
Upcoming
Sonoclot Sonoclot
Sonoclot and TEG/Thrombelastrography and
Upcoming
Global Live Attenuated Vaccines (LAV) Market Global Live Attenuated Vaccines (LAV) Market
The Global Live Attenuated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $2515 million in 2013 and expected to be $3633 million by 2018 at a CAGR of 7.6%. Live Attenuated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Inactivated Vaccines Market Global Inactivated Vaccines Market
The Global Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $1958 million in 2013 and expected to be $2974million by 2018 at a CAGR of 8.7%. Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Sub-unit Vaccines Market Global Sub-unit Vaccines Market
The Global Subunit Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $91 million in 2013 and expected to be $134 million by 2018 at a CAGR of 8.1%. Subunit Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Toxoid Vaccines Market Global Toxoid Vaccines Market
The Global Toxoid Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $468.1 million in 2013 and expected to be $644.8 million by 2018 at a CAGR of 6.6%. Toxoid Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Conjugate Vaccines Market Global Conjugate Vaccines Market
The global conjugate animal vaccine market is mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $201.1 million in 2013 and is expected to reach $305.2 million by 2018 at a CAGR of 8.7% during the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.
Upcoming
Global Recombinant Vaccines Market Global Recombinant Vaccines Market
The Global Recombinant Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $368.9 million in 2013 and expected to be $550.8 million by 2018 at a CAGR of 8.3%. Recombinant Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Dna Vaccines Market Global Dna Vaccines Market
The global DNA animal vaccine market is mainly driven by growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $142.5 million in 2013 and is expected to reach $232.4 million by 2018, at a CAGR of 10.3% for the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.
Upcoming
Animal Vaccines Animal Vaccines
Animal Vaccines and Bacterial vaccines, Viral vaccines,
Upcoming
Synthetic Vaccines Synthetic Vaccines
Synthetic Vaccines and Live Attenuated Vaccines (LAV),
Upcoming
Dentritic Vaccines Dentritic Vaccines
Dentritic Vaccines and Live Attenuated Vaccines (LAV),
Upcoming
Hemodialysis Machines Hemodialysis Machines
Hemodialysis Machines and Hemodialysis Consumables/Supplies adds up to total Hemodialysis Products market. Hemodialysis Machines can be...
Upcoming
2983 reports | Show
Connect With Us
US/CAN : +1-888-502-0539